Todd D Johnson1, Ryan C Hill2, Monika Dzieciatkowska2, Vishal Nigam3, Atta Behfar4, Karen L Christman1, Kirk C Hansen2. 1. Department of Bioengineering, Sanford Consortium for Regenerative Medicine, University of California at San Diego, La Jolla, CA, USA. 2. Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado, Aurora, CO, USA. 3. Department of Pediatrics (Cardiology), University of California San Diego and Rady Children's Hospital, San Diego, La Jolla, CA, USA. 4. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Abstract
PURPOSE: The purpose of this study was to characterize and quantitatively analyze human cardiac extracellular matrix (ECM) isolated from six different cadaveric donor hearts. EXPERIMENTAL DESIGN: ECM was isolated by decellularization of six human cadaveric donor hearts and characterized by quantifying sulfated glycosaminoglycan content (sGAG) and via PAGE. The protein content was then quantified using ECM-targeted Quantitative conCATamers (QconCAT) by LC-SRM analysis using 83 stable isotope labeled (SIL) peptides representing 48 different proteins. Nontargeted global analysis was also implemented using LC-MS/MS. RESULTS: The sGAG content, PAGE, and QconCAT proteomics analysis showed significant variation between each of the six patient samples. The quantitative proteomics indicated that the majority of the protein content was composed of various fibrillar collagen components. Also, quantification of difficult to remove cellular proteins represented less than 1% of total protein content, which is very low for a decellularized biomaterial. Global proteomics identified over 200 distinct proteins present in the human cardiac ECM. CONCLUSION AND CLINICAL RELEVANCE: In conclusion, quantification and characterization of human myocardial ECM showed significant patient-to-patient variability between the six investigated patients. This is an important outcome for the development of allogeneic derived biomaterials and for increasing our understanding of human myocardial ECM composition.
PURPOSE: The purpose of this study was to characterize and quantitatively analyze human cardiac extracellular matrix (ECM) isolated from six different cadaveric donor hearts. EXPERIMENTAL DESIGN: ECM was isolated by decellularization of six human cadaveric donor hearts and characterized by quantifying sulfated glycosaminoglycan content (sGAG) and via PAGE. The protein content was then quantified using ECM-targeted Quantitative conCATamers (QconCAT) by LC-SRM analysis using 83 stable isotope labeled (SIL) peptides representing 48 different proteins. Nontargeted global analysis was also implemented using LC-MS/MS. RESULTS: The sGAG content, PAGE, and QconCAT proteomics analysis showed significant variation between each of the six patient samples. The quantitative proteomics indicated that the majority of the protein content was composed of various fibrillar collagen components. Also, quantification of difficult to remove cellular proteins represented less than 1% of total protein content, which is very low for a decellularized biomaterial. Global proteomics identified over 200 distinct proteins present in the human cardiac ECM. CONCLUSION AND CLINICAL RELEVANCE: In conclusion, quantification and characterization of human myocardial ECM showed significant patient-to-patient variability between the six investigated patients. This is an important outcome for the development of allogeneic derived biomaterials and for increasing our understanding of human myocardial ECM composition.
Authors: John M Wallis; Zachary D Borg; Amanda B Daly; Bin Deng; Bryan A Ballif; Gilman B Allen; Diane M Jaworski; Daniel J Weiss Journal: Tissue Eng Part C Methods Date: 2012-01-26 Impact factor: 3.056
Authors: Jennifer M Singelyn; Priya Sundaramurthy; Todd D Johnson; Pamela J Schup-Magoffin; Diane P Hu; Denver M Faulk; Jean Wang; Kristine M Mayle; Kendra Bartels; Michael Salvatore; Adam M Kinsey; Anthony N Demaria; Nabil Dib; Karen L Christman Journal: J Am Coll Cardiol Date: 2012-02-21 Impact factor: 24.094
Authors: Sonya B Seif-Naraghi; Jennifer M Singelyn; Michael A Salvatore; Kent G Osborn; Jean J Wang; Unatti Sampat; Oi Ling Kwan; G Monet Strachan; Jonathan Wong; Pamela J Schup-Magoffin; Rebecca L Braden; Kendra Bartels; Jessica A DeQuach; Mark Preul; Adam M Kinsey; Anthony N DeMaria; Nabil Dib; Karen L Christman Journal: Sci Transl Med Date: 2013-02-20 Impact factor: 17.956
Authors: Jennifer M Singelyn; Jessica A DeQuach; Sonya B Seif-Naraghi; Robert B Littlefield; Pamela J Schup-Magoffin; Karen L Christman Journal: Biomaterials Date: 2009-07-15 Impact factor: 12.479
Authors: Joshua R Gershlak; Sarah Hernandez; Gianluca Fontana; Luke R Perreault; Katrina J Hansen; Sara A Larson; Bernard Y K Binder; David M Dolivo; Tianhong Yang; Tanja Dominko; Marsha W Rolle; Pamela J Weathers; Fabricio Medina-Bolivar; Carole L Cramer; William L Murphy; Glenn R Gaudette Journal: Biomaterials Date: 2017-02-10 Impact factor: 12.479
Authors: Erica T Goddard; Ryan C Hill; Alexander Barrett; Courtney Betts; Qiuchen Guo; Ori Maller; Virginia F Borges; Kirk C Hansen; Pepper Schedin Journal: Int J Biochem Cell Biol Date: 2016-10-24 Impact factor: 5.085
Authors: Heather M Brechbuhl; Alexander S Barrett; Etana Kopin; Jaime C Hagen; Amy L Han; Austin E Gillen; Jessica Finlay-Schultz; Diana M Cittelly; Philip Owens; Kathryn B Horwitz; Carol A Sartorius; Kirk Hansen; Peter Kabos Journal: JCI Insight Date: 2020-02-27